Amarex Taiwan is committed to supporting COVID-19 clinical trials. Our expert team is working tirelessly to expedite processes and help clients navigate the continually changing developments in this pandemic. We are currently working with a number of clients worldwide to facilitate access to diagnostic, device and therapeutic products.
This page will be updated frequently with new information.
Amarex Submits a CTA to Belgium Health Authorities for a COVID-19 Clinical Trial
On Thursday, May 22, 2020, Amarex on behalf of a client, submitted a Clinical Trial Application (CTA) to Belgium health authorities. The CTA is for a therapeutic product to treat serious side-effects of the COVID-19 disease in a special patient population. Amarex’s Regulatory Affairs team prepared and submitted the application within one week of receiving the request from the client. An approval from Belgium authorities is expected soon.
COVID-19 News & Events